Cardiol Therapeutics (CRDL) Competitors C$2.54 -0.08 (-3.05%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlines CRDL vs. TEV, ABT, NOT, PYR, NVO, SLS, DNA, VBV, CUS, and AIMShould you be buying Cardiol Therapeutics stock or one of its competitors? The main competitors of Cardiol Therapeutics include Tervita (TEV), Absolute Software Co. (ABT.TO) (ABT), Noront Resources (NOT), PyroGenesis Canada Inc. (PYR.V) (PYR), Novo Resources Corp. (NVO.V) (NVO), Solaris Resources (SLS), Dalradian Resources (DNA), VBI Vaccines (VBV), Chemtrade Electrochem Inc, (CUS), and Aimia (AIM). These companies are all part of the "pharmaceutical products" industry. Cardiol Therapeutics vs. Tervita Absolute Software Co. (ABT.TO) Noront Resources PyroGenesis Canada Inc. (PYR.V) Novo Resources Corp. (NVO.V) Solaris Resources Dalradian Resources VBI Vaccines Chemtrade Electrochem Inc, Aimia Cardiol Therapeutics (TSE:CRDL) and Tervita (TSE:TEV) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, media sentiment, community ranking, dividends, earnings and risk. Which has stronger earnings & valuation, CRDL or TEV? Tervita has higher revenue and earnings than Cardiol Therapeutics. Cardiol Therapeutics is trading at a lower price-to-earnings ratio than Tervita, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCardiol TherapeuticsN/AN/A-C$29.34M-C$0.44-5.77TervitaC$1.36B0.00-C$1.04M-C$0.01N/A Is CRDL or TEV more profitable? Tervita's return on equity of 0.00% beat Cardiol Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Cardiol TherapeuticsN/A -108.43% -54.15% Tervita N/A N/A N/A Does the media prefer CRDL or TEV? In the previous week, Cardiol Therapeutics had 1 more articles in the media than Tervita. MarketBeat recorded 1 mentions for Cardiol Therapeutics and 0 mentions for Tervita. Cardiol Therapeutics' average media sentiment score of 0.00 equaled Tervita'saverage media sentiment score. Company Overall Sentiment Cardiol Therapeutics Neutral Tervita Neutral Does the MarketBeat Community favor CRDL or TEV? Tervita received 31 more outperform votes than Cardiol Therapeutics when rated by MarketBeat users. However, 69.23% of users gave Cardiol Therapeutics an outperform vote while only 50.63% of users gave Tervita an outperform vote. CompanyUnderperformOutperformCardiol TherapeuticsOutperform Votes969.23% Underperform Votes430.77% TervitaOutperform Votes4050.63% Underperform Votes3949.37% Do analysts rate CRDL or TEV? Given Tervita's higher possible upside, analysts plainly believe Tervita is more favorable than Cardiol Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cardiol Therapeutics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Tervita 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals and insiders hold more shares of CRDL or TEV? 11.4% of Cardiol Therapeutics shares are held by institutional investors. 4.6% of Cardiol Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. SummaryCardiol Therapeutics and Tervita tied by winning 7 of the 14 factors compared between the two stocks. Ad DTIWhen it comes to NVDA… “acceleration cycles” are the keyExpert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.Use this link to see Nvidia Unchained right away! Get Cardiol Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRDL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRDL vs. The Competition Export to ExcelMetricCardiol TherapeuticsDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapC$177.50MC$1.19BC$5.18BC$6.08BDividend YieldN/A3.13%5.18%5.33%P/E Ratio-5.77106.9967.0026.33Price / SalesN/A3,546.221,269.051,427.12Price / Cash0.9810.3339.9182.02Price / Book11.553.196.493.06Net Income-C$29.34MC$155.49MC$120.13MC$291.48M7 Day Performance-8.63%-0.77%-5.13%-0.14%1 Month Performance-5.58%-2.67%-2.72%-1.45%1 Year Performance117.09%95.74%31.20%42.59% Cardiol Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRDLCardiol TherapeuticsN/AC$2.54-3.1%N/A+122.8%C$177.50MN/A-5.7720TEVTervitaN/AN/AN/AN/AC$672.00MC$1.36B-645.5636,800Gap UpABTAbsolute Software Co. (ABT.TO)N/AN/AN/AN/AC$636.46MC$104.67M63.42115,000High Trading VolumeNOTNoront ResourcesN/AC$1.10-0.5%N/A+0.0%C$612.18MN/A-7.20101,700PYRPyroGenesis Canada Inc. (PYR.V)N/AC$3.85+11.0%N/A+0.0%C$606.96MC$6.01M-154.0090Gap UpNVONovo Resources Corp. (NVO.V)N/AC$2.38-0.4%N/A+0.0%C$548.24MN/A-21.2554,400SLSSolaris Resources1.7273 of 5 starsC$3.32+4.1%N/A-34.2%C$538.64MN/A-7.3810High Trading VolumeDNADalradian ResourcesN/AN/AN/AN/AC$519.02MN/A-56.15640News CoverageVBVVBI VaccinesN/AN/AN/AN/AC$308.86MC$3.36M-4.9722CUSChemtrade Electrochem Inc,N/AN/AN/AN/AC$306.50MN/A0.0060AIMAimia1.614 of 5 starsC$2.55-3.0%N/A-12.4%C$250.87MC$396.20M-1.9220 Related Companies and Tools Related Companies Tervita Alternatives Absolute Software Co. (ABT.TO) Alternatives Noront Resources Alternatives PyroGenesis Canada Inc. (PYR.V) Alternatives Novo Resources Corp. (NVO.V) Alternatives Solaris Resources Alternatives Dalradian Resources Alternatives VBI Vaccines Alternatives Chemtrade Electrochem Inc, Alternatives Aimia Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (TSE:CRDL) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardiol Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardiol Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CRDL Stock Alerts